| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
6e-17 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.27 |
1e-14 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
2e-14 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
3e-14 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
6e-14 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
7e-14 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
3e-13 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.25 |
4e-13 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
9e-12 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-11 |